Clinical performance of a high-efficiency rapid flow leucocyte removal filter for leucocyte depletion of heparinized cardiopulmonary bypass perfusate

Abstract

The method of leucocyte depletion has been recently introduced to the field of cardiopulmonary bypass to reduce leucocyte-mediated organ dysfunction. In this study, we evaluated the efficacy and biocompatibility of the Pall RC400 filters for leucocyte depletion of heparinized cardiopulmonary bypass (CPB) perfusate taken from the heart-lung machine during routine cardiac surgery. For each filter, 700 ml blood were used as filtrate. Filtration was divided into the following groups to study the effect of loading pressure on the efficacy of the filters: under gravity pressure as a control (n = 8), under 100 mmHg (n = 8), 200 mmHg (n = 8), and 300 mmHg loading pressure (n = 8) driven by a roller pump. In addition, heparinized predonation blood taken at the beginning of CPB (n = 8) was filtered under gravity in comparison with the perfusate taken at the end of CPB. The results showed that the average leucocyte removal rate by an RC400 filter for 700 ml of blood was 96.8%. There was no significant difference of leucocyte removal rate between filtration under gravity and under loading pressure up to 300 mmHg. This allows clinical filtration at a speed up to 500 ml/min. The platelet removal rate was significantly higher in blood taken at the beginning of CPB than in blood taken at the end of CPB. Complement split product, C5a, increased only slightly during filtration indicating that this filter, made from polyester, has a good blood compatible characteristic. We conclude that the Pall RC400 leucocyte removal filter is suitable and safe to be used for leucocyte filtration of heparinized CPB perfusate during cardiac surgery.

Get full access to this article

View all access options for this article.

References

Van Oeveren W. , Wildevuur ChRH. Blood compatibility of cardiopulmonary bypass circuits. Perfusion 1987; 2: 237-44.

Kirklin JK Prospects for understanding and eliminating the deleterious effects of cardiopulmonary bypass [Editorial]. Ann Thorac Surg 1991; 51: 529-31.

Butler J. , Rocker GM , Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993; 55 : 552-59.

Gu YJ , van Oeveren W. , Boonstra PW , de Haan J. , Wildevuur ChRH. Leukocyte activation with increased membrane expression of CR3 receptors induced by cardiopulmonary bypass. Ann Thorac Surg 1992; 53: 839-44.

Bando K. , Pillai R. , Cameron DE et al . Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 873-77.

Pearl JM , Drinkwater DC , Laks H. , Capouya ER , Gates RN Leukocyte-depleted reperfusion of transplanted human hearts: A randomized, double-blind clinical trial. J Heart Lung Transplant 1992;11: 1082-92.

Wilson IC , Gardner TJ , DiNatale JM , Gillinov AM , Curtis WE , Cameron DE Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion. J Thorac Cardiovasc Surg 1993;106: 805-810.

Hart S. , Roe JA Leukocyte depleting filters and cardiothoracic surgery. Perfusion 1993; 8 : 477-82.

Gourlay T. , Fleming J. , Taylor KM Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter. Perfusion 1992; 7: 131-40.

10.

Palanzo DA , Manley NJ , Montesano RM , Yeisley GL , Gordon D. Clinical evaluation of the LeukoGuard (LG-6) arterial line filter for routine open-heart surgery. Perfusion 1993 ; 8: 489-96.

11.

Rebulla P. , Dzik WH Multicenter evaluation of methods for counting residual white cells in leukocyte-depleted red blood cells. Vox Sang 1994; 66: 25-32.

12.

Meryman HT Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion. Transfus Med Rev 1989; 3: 180-93.

13.

Lane TA , Anderson KC , Goodnough LT et al. Leukocyte reduction in blood component therapy. Ann Intern Med 1992;117: 151-62.

14.

Eisenfeld L. , Silver H. , McLaughlin et al . Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion 1992; 32: 205-209.

15.

Sirchia G. , Rebulla P. , Parravicini A. , Carnelli V. , Gianotti GA , Bertolini F. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter. Transfusion 1987; 27: 402-405.

16.

Masse M. , Andreu G. , Angue M. et al . A multicenter study on the efficiency of white cell reduction by filtration of red cells. Transfusion 1991; 31: 792-97.

17.

Gu YJ , Obster R. , Haan J. , Gallandat Huet Rcg , Eijgelaar A. , van Oeveren W. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate. Artif Organs 1993; 17: 660-65.